Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients

• Published in: Atherosclerosis 2008-04, Vol.197 (2), p.937-943
• Main Authors: Mazor, Rafi, Shurtz-Swirski, Revital, Farah, Raymond, Kristal, Batya, Shapiro, Galina, Dorlechter, Faina, Cohen-Mazor, Meital, Meilin, Edna, Tamara, Snitkovski, Sela, Shifra
• Format: Article
• Language: English
• Subjects: Acute-Phase Proteins - metabolism; Adult; Apoptosis; Atherosclerosis (general aspects, experimental research); Biological and medical sciences; Blood and lymphatic vessels; Cardiology. Vascular system; Cardiovascular; Cardiovascular system; Case-Control Studies; CD11b Antigen - metabolism; Female; Humans; Hyperlipidemia; Hyperlipidemias - blood; Hyperlipidemias - immunology; Inflammation; Inflammation - blood; Male; Medical sciences; Middle Aged; Myeloperoxidase; Neutrophils - immunology; Oxidative stress; Oxidative Stress - immunology; Peroxidase - blood; Peroxidase - metabolism; Pharmacology. Drug treatments; PMNL priming; Superoxides - blood; Superoxides - metabolism; Vasodilator agents. Cerebral vasodilators
• ISSN: 0021-9150; 1879-1484
• DOI: 10.1016/j.atherosclerosis.2007.08.014

Abstract Background Oxidative stress (OS) and chronic inflammation are involved and contribute to the development of atherosclerosis. Primed polymorphonuclear leukocytes (PMNLs) are a possible source for superoxide radicals and inflammatory mediators, hence can promote OS and inflammation. The involvement of primed PMNLs in clinical states associated with high risk for developing cardiovascular disease and atherosclerosis, such as hypertension, renal failure and diabetes has been described, however, little is known about PMNLs characteristics in hyperlipidemic patients. Methods Hyperlipidemic patients and healthy control (HC) subjects were enrolled in this cross-sectional study. PMNL priming was estimated by measuring the rate of superoxide release and by levels of membrane CD11b. PMNL priming and myeloperoxidase (MPO) levels served as OS indices. Inflammation was linked to peripheral white blood cells and PMNL counts and to apoptosis. Systemic inflammation was estimated by blood levels of fibrinogen, C-reactive protein (CRP), transferrin and albumin. PMNL priming and inflammation parameters were related to the severity of hyperlipidemia. Results PMNLs from hyperlipidemic patients are primed compared to HC. A decrease in PMNL-MPO levels with increased levels of serum MPO were found in hyperlipidemic patients. Leukocyte counts tended to be higher in hyperlipidemic patients with increased PMNL apoptosis. PMNL priming and fibrinogen levels correlated positively with the severity of hyperlipidemia ( r = 0.32, P = 0.02 for CD11b vs. cholesterol and r = 0.38, P = 0.009 for CD11b vs. LDL-c; r = 0.35, P = 0.01 for fibrinogen vs. cholesterol and r = 0.3, P = 0.03 for superoxide release vs. LDL-c). Conclusion PMNLs are primed in hyperlipidemic patients contributing to OS and inflammation in these patients. This study highlights primed PMNLs as an additional risk factor for promoting atherosclerosis in hyperlipidemic patients.